Draft Recommendations & Roadmap

Slides:



Advertisements
Similar presentations
Building a National Medication Reference Terminology:
Advertisements

S.O.S. eHealth Project Open eHealth initiative for a European large scale pilot of patient summary and electronic prescription Daniel Forslund, Head of.
DG Enterprise and Industry Approach on Combating Counterfeit Medicines Council of Europe Conference “Europe against Counterfeit Medicines” Session: Key.
Completing the EU internal energy market IFIEC, 22 November 2011
WG 6 «Pharmacy & Medication» Current activities Porto, Wednesday 11th June 2014.
GS1 Healthcare Roadmap January 2015.
New ISO projects Joint meeting HL7, IHE and ISO Pharmacy groups Leonora Grandia, Z-Index.
EU Directive 2001/83/EC Dr. P. V. Appaji, M.Pharm, Ph.D
Generic Substitution Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
PHC Meeting the global challenge of unique identification of medicinal products Overview of objectives, outcomes and process Contact:
EPrescript Presentation : Presentation : Bernard Wathelet - MediBRIDGE.
HL7 Medication and UKCPRS Julie James Partner Blue Wave Informatics.
Justina A. Molzon, MS Pharm, JD
How can I trust the rest of Europe ? Requirements and a possible organisation with regard to epSOS and eHealth Frank Robben General manager eHealth platform.
EHealth Interoperability – EU Commission activities Dr Octavian Purcarea Unit H1 – ICT for Health Directorate ICT for citizens and businesses DG INFSO.
Best Archival Practice in the Regulation of Medicines: Work on the Guidelines for Agencies for Medicinal Products Ph.D. Arian Rajh Agency for Medicinal.
WHO Workshop on Prequalification of Medicines Programme, Abu Dhabi, October, 2010 Regulatory principles reflected in practice of WHO PQP Milan Smid,
Promoting excellence in social security Building on sector wide commonalities to enhance the benefits of Information.
EHGI and Convergence 21st March DIRECTIVE 2011/24/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 9 March 2011 on the application of patients’
Federal Medication Terminologies (FMT) Enabling Health IT Interoperability.
PDMP & HITI Gap Mitigation Analysis Summary May 6 th, 2014.
Health and Food Safety EU strategy for Pharmaceuticals in the Environment Patrizia Tosetti DG SANTE European Commission China/EU Pharmaceutical Industry.
Compassionate use programs and the European regulatory system Filip Josephson M.D., Ph.D. Clinical Assessor.
The legal aspects of eHealth: the specific case of telemedicine Céline Deswarte ICT for Health Unit, European Commission TAIEX Multi-country seminar on.
IDMP Overview December 2015.
Regulated Product Submission Eileen M. Girten, MS i3 Statprobe 1DIA Education SIAC.
PHC Meeting the global challenge of unique identification of medicinal products SMS, RMS and OMS : Common Terminologies for enabling ISO IDMP.
An agency of the European Union EU ISO IDMP Roadmap to enable eprescription cross-borders Towards a trans-atlantic solution to univocally identify medicinal.
© 2016 Chapter 6 Data Management Health Information Management Technology: An Applied Approach.
PHC Meeting the challenge of open access to medicinal products across the Union openMedicine approach: A brief demonstration illustrating the.
EU and USA Harmonisation of Content and Message Exchange for IDMP Implementation Vada A. Perkins.
Global harmonisation versus national regulatory considerations.
PHC Meeting the global challenge of unique identification of medicinal products Medicinal products (MPs) ID and substitution in cross-border.
WP1: D 1. 3 openMedicine infostructure WP2: D 2
Anne-Marie Yazbeck, PhD National Infoday, Sweden 2017
Paul Houston CDISC Europe Foundation Head of European Operations
Development of national eHealth system
Periodic Safety Update Reports (PSUR)
Information on Medicinal Products
The European Union (EU) policy challenge
CCHIT Roadmap Discussion Items
European Commission 5G Action Plan
EudraVigilance.
DIA Clinical Safety and Pharmacovigilance Community
Recording and Reporting Clinical Trial Results
Inaugural Expert Council EMA London, 25/6/2015 WP1: epSOS use cases and Conceptual Framework epSOS Problems & EMA Solutions Ida Fortino.
WP1: D 1.3 Standards Framework Status June 25, 2015
Inaugural Expert Council EMA London, 25/6/2015 WP1: epSOS use cases and Conceptual Framework epSOS Problems & EMA Solutions Ida Fortino.
Inaugural Expert Council Meeting at E.M.A. London June 25, 2015
I need a medicine while abroad…
CEN TC 251: openMedicine in a win-win perspective
13 September 2018 PHPID and its enabler role for identification of medicines for e-prescription Towards a trans-atlantic solution to univocally identify.
NASs approval time by therapeutic area:
TRACEABILITY REQUIREMENTS UNDER EU GENERAL FOOD LAW
Median approval time for new active substances approved by ICH agencies by approval year Methodology For each new active substance (NAS) approved between.
Medication in Patient Summaries
1 What is EGR? ESTP course on EGR 6-7 September 2016.
Fundamentals of Electronic Submissions and eCTD
The International Consortium for Personalised Medicine
22 February 2019 Trans-Atlantic regulatory cooperation and harmonisation Focus on IDMP: next steps Towards a trans-atlantic solution to univocally identify.
Metadata The metadata contains
, editor October 8, 2011 DRAFT-D
Medication in Patient Summaries
Improvements and clarifications eP cross-border
Global Medical Device Nomenclature (GMDN)
Gap analysis between Article 57(2) of EC Regulation and the epSOS eP
Inaugural Expert Council EMA London, 25/6/2015 WP1: epSOS use cases and Conceptual Framework epSOS Problems & EMA Solutions Ida Fortino.
Process mapping of registration to reimbursement for new pharmaceuticals in UK Description: A systematic methodology was developed in order to create the.
© empirica – Information provided ‘Commercial in Confidence’
Presentation transcript:

Draft Recommendations & Roadmap openMedicine Workshop Washington, June 21th , 2016

openMedicine US-EU Workshop 2016 Patient has the right to get the for him most appropriate medicinal treatment when being abroad this includes that: medicinal products, if available on that market, can be identified as identical, similar and/or equivalent to his usual products those medicinal products can be dispensed (same or similar rules of dispensing / substitution applicable) openMedicine US-EU Workshop 2016

openMedicine Workshop IHIC 2016 What do we need? an identifier, globally uniqe language independent country independent medicinal product name independent authorisation independent authorisation holder independent or a set of identifying attributes (active) substance(s) Strength dosage form route of administration expressed by using “using standards” openMedicine Workshop IHIC 2016

ISO Identification of Medicinal Products The cornerstone of the ISO standards for the Identification of Medicinal Products Substance Dose Form Strength Regulated Medicinal Product Pharmaceutical Product Pharmaceutical Dose Form Standard Terminology 11615: Regional 11616: Derived 11238: G-SRS & SMS Upcoming milestone information will be used to inform the Action Plan 11240:UCUM 11239:EDQM

openMedicine Workshop IHIC 2016 What do we have? Lifecycle of a medicine (from substance to package) Potential for 6 different identifiers 1 concept does not have an identifier 2 of them are “cross frontiers” Substance G-SRS Pharmaceutical Product Medicinal Product MPName MPID Package PCID European Market Authorisation Number EU-MAN National Market Authorisation Number PL-MAN openMedicine Workshop IHIC 2016

The solution (…continue): 27 June 2018 The solution (…continue): FDA algorithm (beta) for PhPID Generation Substance 1 Substance 2 Substance n Dose form Substance ID Strength Substance ID Strength Alphabetic order of UNII code ・・・ Input NCI thesaurus code UNII code Normalized unit UNII code Normalized unit MD5 digestion MD5 is a widely used algorithm for hash function. PhPID code (example) 128 bit (16 byte) number which, in hexadecimal presentation, is 32 digits long formatted in groups of 8-4-4-4-12  digits separated by hyphens -Globally Unique Identifier (GUID) Output

Recommendations (initial) … Target audience : to enable univocal identification European Commission: is about “cross border” EMA … as “coordinator” EMA … as “authentic source” EMA & FDA… issuing the unique identifier JAseHN… definition of the “guidelines” National regulatory authorities, as partners of EMA Ministry to issue laws and regulations based on the guidelines …Target audience: to get it operational Drug database providers EHR / Prescription system vendors Dispensing applications Patient summary managing systems openMedicine Workshop IHIC 2016

Recommendations regarding central services EMA, FDA, Regulatory authorities,.. Everything starts with the decision of EMA/FDA to initiate the process Make the EU_MAN available… unique identifier based on EU level authorisation sufficient as such within Europe Assign systematically a PhPID (first) to all new drugs ? distribution policy and tool developments The article 57 §2 database should be converted as soon as possible into a structured and as much as possible coded, based on the IDMP suite Develop viewer interface Develop export to the drug database providers openMedicine Workshop IHIC 2016

Recommendations regarding central services European Commission Issue adapted guidelines for ePrescription, eDispensing and Patient Summaries Initiate harmonisation of rules regarding substitution Regulatory authorities Assign centrally the EU_MAN or assign a national PL_MAN … involved in assigning the PhPID openMedicine Workshop IHIC 2016

Recommendations regarding ePrescription Functional integration of the PhPID in ePrescribing Either effective integration into the prescription message Or through centralised mappings services Drug databases Make the PhPID available at the point of prescription Make other ID’s available too HL7, IHE and analogues Enable more than one identifier in a prescription message EHR applications Enable storage of several identifiers Include at least the PhPID in a patient summary openMedicine Workshop IHIC 2016

Recommendations regarding the patient summary Distinguish the concept “medication” and “prescription history “ Include the PhPID in the patinet summary Use the package ID in the prescription history Use the MPID to identify a medicinal product in a medication list openMedicine Workshop IHIC 2016